Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00068276 · ClinicalTrials.gov registry record · Phase 2
Cholecalciferol in Treating Patients With Myelodysplastic Syndrome
A Phase 2 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00068276 is a Phase 2 study that has completed, run by Wake Forest University Health Sciences.
The verdict
NCT00068276, a Phase 2 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Cholecalciferol (vitamin D) may improve quality of life by increasing blood counts, decreasing fatigue, and improving other symptoms of myelodysplastic syndrome. PURPOSE: This phase II trial is studying how well cholecalciferol works in treating patients with myelodysplastic syndrome.
Interventions
- DIETARY_SUPPLEMENT cholecalciferol
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-07 |
| Est. Completion | 2006-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00068276
The ClinicalTrials.gov registry entry for NCT00068276 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which cholecalciferol is the first listed.
NCT00068276 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00068276 about?
NCT00068276 is a clinical study titled "Cholecalciferol in Treating Patients With Myelodysplastic Syndrome". RATIONALE: Cholecalciferol (vitamin D) may improve quality of life by increasing blood counts, decreasing fatigue, and improving other symptoms of myelodysplastic syndrome. PURPOSE: This phase II trial is studying how well cholecalciferol works in treating patients with myelodysplastic syndrome.
What is the current status of trial NCT00068276?
This trial is currently completed. It is a Phase 2 study. The study started on 2003-07. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00068276?
The interventions under investigation include: cholecalciferol (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00068276?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.